Haohai Biological Technology (06826.HK) is a leading company in China focusing on R&D, manufacturing and sales of biomedical materials. We strategically target the fast-growing therapeutic areas in the biomedical materials market including ophthalmology, medical aesthetics and would healing, orthopedics, and anti-adhesion and hemostasis. We currently manufacture intraocular lens (IOL), medical sodium hyaluronate, medical chitosan, medical collage sponge, rhEGF, etc. Based on the sales volume of the Company's IOL and the number of national cataract surgery cases, the Company has captured about 30% of the IOL market in the PRC. Meanwhile, the market share of Company's anti-adhesion products, OVD products and orthopedics viscosupplementation products was 49.05%, 45.93%, and 36.21%, respectively.
We're tracking SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.'s market expansion
How SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.'s international expansion compares to its competitors
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.YouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.You | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Global water needle market to reach 23.8 billion yuan by 2032, growing at 10.6% CAGR. Market driven by increasing demand for non-surgical beauty treatments and skin hydration.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.'s business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
